BRCA1/2 mutations (14.6%–22.8%) were more likely found in high‐grade serous carcinoma of ovarian than other types of ovarian cancer (Alsop et al., 2012; Candido‐dos‐Reis et al., 2015; Harter et al., 2016). Here, BRCA1 is linked to serous adenocarcinoma.